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CLCA1: Calcium-activated chrloride channel regulator 1 
DAPT: GSI-IX, LY-374973, N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester 
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2-yl)thio]-acetamide 
KIAA1324: UPF0557 protein 




SLC27A4: Long-chain fatty acid transport protein 4 
TFF3: Trefoil factor 3 
UGT2B17: UDP glucuronosyltransferase family 2 member B17 
Wnt: Wingless-related MMTV integrated site 
ZG16: Zymogen 16 
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Recently, three-dimensional small intestinal organoids (enteroids) have been developed from 
cultures of intestinal stem cells which differentiate in vitro to generate all the differentiated 
epithelial cell types associated with the intestine and mimic the structural properties of the intestine 
observed in vivo. Small-molecule drug treatment can skew organoid epithelial cell differentiation 
towards particular lineages, and these skewed enteroids may provide useful tools to study specific 
epithelial cell populations, such as goblet and Paneth cells. However, the extent to which 
differentiated epithelial cell populations in these skewed enteroids represent their in vivo 
counterparts is not fully understood. In this study, we have performed label-free quantitative 
proteomics to determine whether skewing murine enteroid cultures towards the goblet or Paneth 
cell lineages results in changes in abundance of proteins associated with these cell lineages in vivo. 
Our data confirm that skewed enteroids recapitulate important features of the in vivo gut 
environment, confirming that they can serve as useful models for the investigation of normal and 
disease processes in the intestine. Furthermore, by comparison of our mass spectrometry data with 
histology data contained within the Human Protein Atlas, we identify putative novel markers for 
goblet and Paneth cells.  
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The small intestine is organised into protruding finger-like villi, and crypts of Lieberkühn which 
extend into the muscularis mucosae. These structures are covered by a single layer of epithelium 
consisting of specialised cell types, including absorptive enterocytes, goblet cells, enteroendocrine 
cells, M cells and Paneth cells [1,2]. Goblet and Paneth cells play crucial roles in protecting the host 
from microbial invasion, and in regulating the commensal flora. Goblet cells produce a protective 
mucus layer that is loosely adhered to the intestinal epithelium, and acts as a barrier to pathogen 
colonisation and invasion [3,4]. Furthermore, they have been shown to play a role in luminal antigen 
sampling across the small intestinal epithelium [5]. Paneth cells reside at the crypt base, and secrete 
antimicrobial compounds into the crypt lumen following antigenic stimulation [6–9]. Systems based 
approaches have the potential to provide a more holistic view of the development and host-
protective role of these epithelial cell populations. However, their relative scarcity in the epithelial 
cell layer, combined with complexities in the isolation and culture of these cells, pose a significant 
barrier to the application of unbiased profiling techniques, such as proteomics, to study these cells.  
 
The small intestinal epithelium undergoes regular renewal via shedding of epithelial cells into the 
mucus layer, which is removed along with other gastrointestinal waste. Intestinal epithelial 
regeneration requires the presence of LGR5+ stem cells, which reside at the crypt base and are 
capable of generating all the specialised epithelial cell types found in the small intestine [10,11]. A Wnt 
gradient exits along the crypt-villus axis, originating in the crypt domain. Wnt-signalling maintains 
LGR5+ cell proliferation in the crypt. As daughter cells migrate along the Wnt gradient, crosstalk 
between Wnt, Notch and BMP signalling determines cell fate, giving rise to differentiated epithelial 
lineages. These renewal properties can be exploited to generate three-dimensional organoid 
cultures (called enteroids) from isolated intestinal LGR5+ stem cells or crypts [12]. When cultured in 
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Matrigel® with a cocktail of growth factors, LGR5+ stem cells generate the differentiated epithelial 
cell types found in the small intestine, arranged in crypt-villus structures that mimic the complex 
intestinal architecture observed in vivo [12]. Since the initial description of these cultures in 2009, 
there has been a dramatic uptake in their use as in vitro models of a variety of different physiologic 
and pathologic processes. Consequently, characterisation of the enteroid proteome would serve as a 
valuable resource in this growing field. 
 
Enteroids can be treated with small molecule inhibitors to skew cell differentiation towards specific 
lineages [13–15]. For example, the combination of DAPT and CHIR99021, which inhibit notch signaling 
and GSK3β-mediated β-catenin degradation respectively, directs epithelial cell differentiation 
towards the Paneth cell lineage [15]. If DAPT is instead combined with an inhibitor of Wnt signaling, 
IWP-2, epithelial cells are directed along the secretory cell lineages resulting in cultures enriched for 
goblet cells [15]. These skewed enteroids might allow systems approaches to be applied to study the 
host-defensive properties of specialized intestinal epithelial cells that have up until now evaded 
culture ‘in vitro’. However, the extent to which differentiated epithelial cell populations generated 
from enteroids represent their in vivo counterparts is not fully understood [16–23].  
 
Four biological replicates of drug-skewed enteroid cultures were generated from murine small 
intestinal crypts essentially as previously described [12]. For drug skewing, media was changed on 
days two, five and seven to include 10μM DAPT and either 3μM CHIR99021 or 2μM IWP-2 (Tocris, 
Oxford, United Kingdom) [15]. On day eight, enteroids were fixed and prepared for confocal imaging 
as described in the Supporting informtion.  
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In DAPT and CHIR-treated enteroids (“Paneth-skewed”), we observed a higher proportion of cells 
stained with a Paneth cell marker, lysozyme, compared to control cultures (Figure S1A). In DAPT and 
IWP-2-treated enteroids (“Goblet-skewed”), we observed a greater proportion of cells stained with 
the goblet cell marker, MUC2, when compared to control enteroid cultures (Figure S1B). These 
changes in expression of canonical markers of differentiated epithelial cell types confirm the success 
of small molecule inhibitors in directing the differentiation of LRG5+ stem cells towards specific 
epithelial cell lineages. 
 
For mass spectrometry, a minimum of 50 organoids per treatment group were extracted from 
Matrigel® using Cell Recovery Solution (BD Bioscience). Proteins were extracted in solution using 
50mM ammonium bicarbonate, 0.2% w/v Rapigest (Waters) and protein content was normalised 
between samples.  Trypsin digested peptide mixtures (2µl) were analysed by on-line nanoflow liquid 
chromatography using the nanoACQUITY-nLC system (Waters MS technologies, Manchester, UK) 
coupled to an LTQ-Orbitrap Velos (ThermoFisher Scientific, Bremen, Germany) mass spectrometer 
with the manufacturer’s nanospray ion source. Sample injections were not grouped by treatment 
type to avoid any batch bias. Protein identification and quantification were performed using 
Progenesis LC-MS for proteomics (v 4.1, Nonlinear Dynamics) and the Mascot search engine (v 
2.3.02, Matrix Science), using the parameters described in the supporting information. 
 
Using an exclusion criteria of ≥ 2 peptides identified, we identified a total of 1574 proteins in Paneth-
skewed, and 1471 proteins in goblet-skewed enteroids. Applying exclusion criteria of log2 fold 
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change > 1 and q value (ANOVA) < 0.05 (FDR adjusted p value), 36 proteins were up-regulated and 
65 proteins were down-regulated in Paneth-skewed enteroids compared to untreated controls 
(Figure 1A-B, Table S1). In goblet-skewed enteroids, 55 proteins were up-regulated, and 153 down-
regulated compared to untreated controls (Figure 1C-D, Table S2). Thus, treatment with DAPT/CHIR 
or DAPT/IWP-2 results in distinct patterns of protein expression. 
 
We next determined if the observed changes in protein abundance in Paneth-skewed cultures were 
reflective of known features of Paneth cells observed in vivo. Matrilysin (MMP7), a known marker of 
Paneth cells required for activation of pro-α-defensins, was significantly upregulated (log2 fold 
change = 1.78, q value = 0.00093, Table S1) [24]. We also observed an increased abundance of several 
α-defensins (DEFA4, DEFA5, DEFA7, DEFA20, DEFA22, DEFA24) though none reached statistical 
significance. To confirm that proteins found to be significantly up-regulated in Paneth-skewed 
cultures were also expressed by Paneth cells in vivo, we performed searches for human homologues 
of the proteins on The Human Protein Atlas (http://v13.proteinatlas.org, and Supporting 
Information)[25]. Paneth cells were identified as granular cells residing at the base of small intestinal 
crypts, and antibody staining for Paneth cell products, lysozyme (LYZ) and defensin α5 (DEFA5), used 
as a reference (Figure 2A,B). Of the 36 proteins upregulated, expression of MMP7, KIAA1324, 
SLC27A4, and DNAJC3 was restricted to, or enriched within, Paneth-like cells (Figure 2C-F). Of these 
proteins, only MMP7 and DNAJC3 were uniquely upregulated in Paneth-skewed enteroids. To cope 
with their secretory demands, Paneth cells require a highly developed endoplasmic reticulum (ER)[26] 
which is protected from ER stress by the unfolded protein response (UPR). Intestinal epithelial cell-
specific deletion of the UPR gene, Xbp1, leads to induction of ER stress, and a profound defect in 
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Paneth cells [27]. Since DNAJC3 also plays a role in attenuation of ER stress[26], we hypothesise that 
DNAJC3 may be important for Paneth cell development and function. 
 
Goblet cells secrete mucins which form a protective mucus layer that maintains physical separation 
between the host epithelium and colonising microbes. To determine if the observed changes in 
protein abundance in goblet-skewed cultures were reflective of differentiation towards the goblet 
cell lineage, proteomic profiles were cross-compared with a published database of murine small 
intestinal mucus components [28]. Of the 56 significantly up-regulated proteins within our goblet-
skewed enteroids, 14 (25%) were also detected in murine gastrointestinal mucus [28] (Table S3). Of 
these, CLCA1 (log2 fold change = 3.328, q value = 0.00347), AGR2 (log2 fold change = 1.857, q value = 
0.04257) and ZG16 (log2   fold change = 2.26, q value = 0.03612) are among the most highly 
abundant constituents of gastrointestinal mucus. Our data therefore support the idea that goblet-
skewed enteroid cultures accurately recapitulate the in vivo environment, and may be useful models 
of goblet cell function. Indeed, goblet skewed colonic enteroids have been used to study the role of 
autophagy genes in mucus secretion [29]. 
 
To further confirm that proteins found to be significantly up-regulated in goblet-skewed cultures 
were also expressed by goblet cells in vivo, we again performed searches for human homologues of 
the proteins in The Human Protein Atlas (http://v13.proteinatlas.org, and Supporting Information) 
[25]. Goblet cells were identified based on the presence of mucin granulae filling the cytoplasm at the 
apical surface, and antibody staining for a canonical marker of goblet cells, TFF3, was used as a 
reference (Figure 3A). Of the 55 proteins upregulated, TFF3, CLCA1, ZG16 and UGT2B17 expression 
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was restricted to, or enriched within, Goblet cells (Figure 3A-D). TFF3, CLCA1 and ZG16 have 
previously been associated with mucus production. Across a large panel of normal tissues 
encompassing all major organ systems, the Human Protein Atlas states that goblet cells show the 
strongest positivity for the remaining protein, UGT2B17.  
 
Finally, we observed some commonalities in the proteins up or down-regulated in response to both 
DAPT/CHIR or DAPT/IWP-2 treatment. For example, OLFM4, an anti-apoptotic factor and marker of 
intestinal stem cells, was significantly down-regulated under both treatment conditions, while 
expression of the canonical enteroendocrine cell marker, CHGA, was significantly up-regulated in 
both Paneth- and goblet-skewed enteroids (Table S4). This result is in close agreement with a 
previous study which used chga mRNA levels to show that treatment with both DAPT/CHIR and 
DAPT/IWP-2 results in increased differentiation towards the enteroendocrine lineage[15]. Finally, 
UPP1 and NUCB2 staining were observed in both Paneth and goblet cells (Figure 3E,F). 
 
In this study we have subjected murine enteroids to quantitative label-free proteomics, and shown 
that Paneth and goblet cells generated from intestinal stem cells in vitro share features typical of 
these cell types observed in vivo. This study has also lead to the identification of novel protein 
markers not previously associated with these cell populations. Our data therefore support the use of 
Paneth or goblet-skewed enteroids as a means of applying systems approaches to the study of 
infection of intestinal epithelial surfaces with pathogens. 
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Figure 1. Drug treatment skews enteroids towards Paneth or Goblet cell lineages. Intestinal 
enteroids were treated with DAPT/CHIR or DAPT/IWP-2 to promote differentiation towards the 
Paneth or goblet cell lineages, respectively. (A) Volcano plot depicting changes in protein expression 
between control and Paneth-skewed enteroids. (B) Top 10 proteins up- and down-regulated in 
Paneth-skewed enteroids (C) Volcano plot depicting changes in protein expression between control 
and Goblet-skewed enteroids. (D) Top 10 proteins up- and down-regulated in Goblet-skewed 
enteroids.  
 
Figure 2. Intestinal expression patterns of proteins up-regulated in Paneth-skewed cultures. 
Proteins up-regulated in Paneth-skewed enteroids were cross-referenced with immuno-
histochemical staining of normal human tissue available in the Protein Atlas. (A-B) Immuno-
histochemical staining for known Paneth cell markers DEFA5 and LYZ. (C-G) Immuno-histochemical 
staining for a selection of proteins found to be up-regulated in Paneth-skewed enteroid cultures, and 
also expressed in Paneth cells in human intestinal tissue. Pink regions highlight crypts, while green 
regions highlight villi. Arrows indicate Paneth cells (in crypt regions) or goblet cells (in villus regions). 
Images from v13.proteinatlas.org . 
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Figure 3. Intestinal expression patterns of proteins up-regulated in goblet-skewed cultures. 
Proteins up-regulated in goblet-skewed enteroids were cross-referenced with immuno-
histochemical staining of normal human tissue available in the Protein Atlas. (A) Immuno-
histochemical staining for a known goblet cell marker, TFF3. (A-D) Immuno-histochemical staining 
for a selection of proteins found to be up-regulated in goblet-skewed enteroid cultures, and also 
expressed in goblet cells in human intestinal tissue. Pink regions highlight crypts, while green regions 




Figure S1. Drug treatment skews enteroids towards Paneth or Goblet cell lineages. Intestinal 
enteroids were treated with DAPT/CHIR or DAPT/IWP-2 to promote differentiation towards the 
Paneth or goblet cell lineages, respectively. (A) Confocal microscopy of β-catenin (red) and Lysozyme 
(green) in un-treated control and DAPT/CHIR treated enteroid cultures. (Β) Confocal microscopy of E-
cadherin (green) and mucin-2 (red) in untreated control and DAPT/IWP-2 treated enteroid cultures. 
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